Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Finished Goods: 2017-2019

Historic Finished Goods for Ironwood Pharmaceuticals (IRWD) over the last 2 years, with Dec 2019 value amounting to $191,000.

  • Ironwood Pharmaceuticals' Finished Goods was N/A to $191,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $191,000, marking a year-over-year change of. This contributed to the annual value of $191,000 for FY2019, which is N/A change from last year.
  • As of FY2019, Ironwood Pharmaceuticals' Finished Goods stood at $191,000, which was down 74.01% from $735,000 recorded in FY2017.
  • In the past 5 years, Ironwood Pharmaceuticals' Finished Goods ranged from a high of $735,000 in FY2017 and a low of $191,000 during FY2019.
  • In the last 2 years, Ironwood Pharmaceuticals' Finished Goods had a median value of $463,000 in 2017 and averaged $463,000.